News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Alex Keown

news@biospace.com

BioSpace News - By Alex Keown
This is What Happens When the FDA Approves Cancer Drugs Too Quickly 8/17/2017
Johnson & Johnson (JNJ) CEO Backpedals and Quits Right Before Trump Disbands Council 8/17/2017
Arcus Biosciences, Wuxi Biologics Hammer Out R&D Cancer Pact Worth $816 Million+ 8/17/2017
Jounce (JNCE) Names Ex-Ariad (ARIA)'s Top Dealmaker as Its New CBO 8/16/2017
How Eli Lilly (LLY) Allegedly Used a Fake Rule and Fake News to Protect Bad Patents 8/16/2017
Struggling Teva (TEVA) Seeks Partners to Fund Some Projects in Its Drug Pipeline 8/16/2017
What You Need to Know About Merck & Co. (MRK)'s Fearless CEO Ken Frazier 8/15/2017
Merck & Co. (MRK) CEO Resigns From President Trump's American Manufacturing Council by Tweet 8/15/2017
As Its CEO Retires, Cerecor (CERC) Divests Depression Drug to Pharma Giant in $45 Million Deal 8/15/2017
Vicarius Pharma Launches With $21.8 Million and Will be Helmed by Former Biogen (BIIB)-Elan (ELN) Exec 8/15/2017
Tiny Virtual Biotech CellAct Forges $250 Million Chemo R&D Pact With Mundipharma 8/15/2017
Biotech Startup Prelude Therapeutics Gets Grant to Triple Its Workforce 8/15/2017
Zeria Pharmaceutical Employee's Death Was 'Job-Related' 8/14/2017
Biogen (BIIB) Quietly Registered Biogen Korea in South Korea Last Month 8/14/2017
Perrigo (PRGO) Unveils Sale of Two Business Units 8/14/2017
Galapagos (GLPG.BR)' Phase II Results With GLPG1690 are 'Extremely Exciting' 8/14/2017
Takeda (TKPYY) Teams Up With Marvel Comics on Inflammatory Bowel Disease Graphic Novel 8/11/2017
Peregrine (PPHM) Slashes Workforce by 20% in Cost Cutting Plan 8/11/2017
Gilead (GILD)'s HIV Triple Combo Gets Sped-up FDA Review, Decision Date Locked Down 8/11/2017
Pharma Bro Martin Shkreli's New Startup Is Hiring 8/11/2017
Former PTC Therapeutics (PTCT) Exec Jumps Ship to Orchard Therapeutics as CEO 8/11/2017
World's Largest Generic Drugmaker Teva (TEVA) Looks to Sell Medis Business 8/11/2017
Race Heats Up As Mallinckrodt (MNK) Gets Bids 8/10/2017
San Diego-based Biotech Expands for Future Growth and Top Talent 8/9/2017
Cempra (CEMP) Seals Merger Deal With This Antibiotics Biopharmaceutical 8/9/2017
Startup MyndYou Using AI to Treat Alzheimer’s Disease 8/9/2017
Bay Area Galena Biopharma  (GALE) Merges With Oncology-Focused Biopharma in All-Stock Deal 8/9/2017
Aclaris (ACRS) Scoops Up St. Louis Startup in Deal Worth Up to $100M 8/8/2017
Esperion (ESPR) Stock Gains On Strong Phase II Data 8/8/2017
New CEO Takes Over Rapamycin, Leads Funding Round With Plans for IND 8/8/2017
Notorious 'Pharma Bro' Martin Shkreli Found Guilty, Faces Up to 20 Years in Prison 8/8/2017
Teva (TEVA) to Cut 7,000 Jobs, Halt Operations in 45 Countries 8/8/2017
AbbVie (ABBV) Wins FDA Approval for the First-Ever Drug to Treat All Forms of Hep C 8/7/2017
Pharma Scores Big Win: Trump to Ink FDA User Fee Bill, Saving 5,000 Jobs 8/7/2017
Mallinckrodt (MNK) to Snap Up Pennsylvania Drugmaker For Up to $425M 8/7/2017
Gemphire Shares Drop on Disappointing Phase II Results for LDL Drug 8/7/2017
FDA Advisory Panel Votes Against Approval Of Johnson & Johnson (JNJ)’s Sirukumab 8/4/2017
Former Google (GOOG) Exec Steps Down as GRAIL CEO 8/4/2017
Ocular Therapeutix (OCUL) to Slash Jobs After FDA Rejection 8/4/2017
QPS Holdings to Double Workforce in Expansion 8/4/2017
4 Clinical Projects Shelved From Pfizer (PFE)’s Pipeline 8/3/2017
Former Biotech CEO Accused of Defrauding Investors 8/3/2017
Pharma Giant AstraZeneca PLC (AZN) Scores Another FDA Breakthrough 8/3/2017
FDA Calls AstraZeneca PLC (AZN) and MedImmune (AZN)’s Imfinzi a Breakthrough 8/2/2017
8 PDUFA Dates to Watch in August 8/2/2017
PixarBio Slashed Headcount, Evicted from Medford Headquarters 8/2/2017
AstraZeneca PLC (AZN) Seen as “Tricky” Takeover Target After Big Setback Last Week 8/2/2017
Following Recent Death, InVivo Therapeutics (NVIV) Temporarily Halts Enrollment in INSPIRE Study 8/2/2017
FDA Raises Big Safety Concerns With Johnson & Johnson (JNJ)'s Arthritis Drug Sirukumab 8/1/2017
Milestone Pharma Banks $55M, Advances Etripamil into Phase III and Expands Headcount 8/1/2017
Mankind Pharma’s Subsidiary Lifestar Pharma Expands R&D in RTP Hub 8/1/2017
Bristol-Myers Squibb (BMY), Clovis Oncology (CLVS) Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III 8/1/2017
FDA Calls Roche (RHHBY)'s Leukemia Drug a Breakthrough 7/31/2017
Why AstraZeneca PLC (AZN)'s MYSTIC Trial Failure May be a Bad Sign for Bristol-Myers Squibb (BMY) 7/31/2017
AstraZeneca PLC (AZN) Seals a $8.5 Billion R&D Cancer Tie-Up With Merck & Co. (MRK) 7/28/2017
AstraZeneca PLC (AZN) Loses $10 Billion in Value as Long-Awaited MYSTIC Trial Disappoints 7/28/2017
Boston Scientific (BSX) Warns of Fluke Death Involving Its S-ICD Pacemaker 7/28/2017
FDA Head Postpones Layoff Notices of Thousands of Employees 7/28/2017
Not-Yet Sold Tesaro (TSRO) Bags $340 Million Cancer Deal With Pharma Giant Takeda (TKPYY) 7/28/2017
Death Count Rises for Patients on Dynavax (DVAX)'s Hep B Vaccine But Overall Rate Was Low, Says the FDA 7/27/2017
Heads Up Startups: Silicon Valley VC Firm—With an Appetite for Biotech—Nabs Record $800 Million Fund 7/26/2017
Merck & Co. (MRK) Plans to File NDA for HIV Treatment Doravirine Based on Phase III Results 7/26/2017
2 Tiny Cancer Biotechs That Could Gain Steam by Year-End 7/26/2017
Merck & Co. (MRK) Dealt Another Setback as Its Ace Keytruda Comes Up Short in Head and Neck Cancer Study 7/26/2017
Japanese Pharma Giant Astellas (ALPMY) Sets Up Shop in Cambridge 7/25/2017
Blood Clot Fears Delay Eli Lilly (LLY), Incyte (INCY)'s Potential Rheumatoid Arthritis Blockbuster, Stocks Fall 7/25/2017
Mitsubishi Tanabe Coughs Up $1.1 Billion Cash for This Parkinson's Biotech 7/25/2017
Teva (TEVA) to Slash Up to 350 Employees in Reorg 7/25/2017
Massachusetts’ Histogenics Looks to NeoCart for Replacing Knee Cartilage Loss 7/25/2017
Bay Area's Nektar (NKTR) Inks $400 Million+ Autoimmune Disease Pact With Eli Lilly (LLY) 7/25/2017
Texas Officials Lure Life Sciences Companies Like Merck & Co. (MRK), Which is Expected to Employ 600 7/25/2017
AstraZeneca PLC (AZN) CEO Breaks Silence on Teva (TEVA) Rumors, Urges Staff to Remain Focused in Leaked Memo 7/24/2017
Ablynx (ABLYF) Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi (SNY) 7/21/2017
Vertex (VRTX) Gains $8 Billion Overnight as Cystic Fibrosis Combo Drug Wows in Trials 7/21/2017
Bay Area Nektar (NKTR)' Comeback is Stalled as the EMA Rejects Breast Cancer Drug 7/21/2017
Endo International (ENDP) Slashes 875 Jobs and Will Shutter Alabama Facilities 7/21/2017
New Braeburn Pharma CEO Has Company on Track with Filing for Opioid Addiction Drug NDA 7/21/2017
Roche (RHHBY) Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics 7/21/2017
Ironwood (IRWD)'s Potential Blockbuster Drug Meets Main Goals in Mid-Stage Trial 7/21/2017
FDA Green Lights Gilead (GILD)'s Vosevi, With a Black Box Warning Attached 7/20/2017
Puma Biotech (PBYI) Surges After the FDA Officially Approves Breast Cancer Drug 7/19/2017
How AstraZeneca PLC (AZN)'s Silence Led to a $4 Billion Loss Overnight 7/19/2017
Another Alzheimer's Let-Down as FUJIFILM's Candidate Flunks Phase II Test 7/19/2017
Siemens Breaks Ground on $300 Million Expansion in Walpole, Mass., Plans for 700 New Jobs 7/19/2017
CDMO Alcami to Move HQ to RTP, New Jobs Expected 7/18/2017
AstraZeneca PLC (AZN) Confirms CEO is Staying Put—For Now 7/18/2017
Radius Health (RDUS)'s Longtime CEO Out, Former Novo Nordisk A/S (NVO) Exec Named New Leader 7/18/2017
The Quest of the Ambitious New Generation of Family-Run Boehringer Ingelheim 7/18/2017
Gottlieb Lays Out Plans to Attract and Preserve Top Talent at the FDA 7/18/2017
Sources Reveal Tesaro (TSRO) is Unlikely to Find a Buyer 7/17/2017
Teva (TEVA) Accuses Former Top Exec of Passing on Trade Secrets to Boyfriend—CEO of Rival Apotex 7/17/2017
Bay Area's Booming CS Bio Submits Plans for New Complex to Triple the Size of Its Workforce 7/17/2017
Rumor Alert: AstraZeneca PLC (AZN) CEO to Become Teva (TEVA)'s New Leader 7/14/2017
Merck KGaA (MKGAF.PK) to Shutter Four Sites, Lay Off 200 Employees 7/14/2017
Cash-Strapped Alder Biopharma (ALDR) Secures $160 Million in Stock Sale to Continue Operations 7/14/2017
Bay Area's E-Scape Bio Bursts Out of Stealth Mode With $63 Million to Tackle Alzheimer's 7/13/2017
5 Drug Stocks That Could be Big Winners in Q2 Earnings 7/13/2017
Cost-Cutting Continues as AstraZeneca PLC (AZN) Unloads U.S. HQ in $50 Million Deal 7/13/2017
Two Bay Area Diagnostic Companies Win Amgen (AMGN)'s Golden Ticket 7/12/2017
Bay Area's OncoMed (OMED) Tanks Some More as GlaxoSmithKline (GSK) Walks Away From R&D Pact 7/12/2017
Backed by Google (GOOG), Evelo Bags $50 Million and Names Some Industry Vets to the Team 7/12/2017
'Retired' Celgene (CELG) Alum Lands Chairman Gig at Biotech Guru Ramaswamy's Dermavant 7/11/2017
Groundbreaking: Amicus (FOLD) Surges as the FDA Changes Its Tune on Fabry Disease Drug 7/11/2017
Waiting Lists are Already Forming for Novartis AG (NVS) and Kite Pharma (KITE)'s Not-Yet Approved CAR-T Drugs 7/11/2017
Neothetics (NEOT) to Slash an Unknown Number of Jobs, Review Strategic Alternatives 7/11/2017
Production Problems Lead Pacira (PCRX) to Cut Jobs in San Diego 7/11/2017
Booming Jazz Pharma (JAZZ) Inks Huge Lease in Philadelphia to Accomodate Growth 7/10/2017
Alexion (ALXN) is Under Investigation by the HHS Office of Inspector General 7/10/2017
Patient Deaths Prompt the FDA to Suspend Three of Merck & Co. (MRK)'s Keytruda Trials 7/7/2017
3 Biotechs That Could be Sweet M&A Targets for Big Pharma 7/7/2017
Bay Area's Biggest Startup Factory Looks to Fund This New Type of Biotech 7/7/2017
Interleukin Genetics (ILGN) Slashes 63% of Workforce, Shuts Down Program and Mulls Sale 7/6/2017
Court Papers Reveal AstraZeneca PLC (AZN) CEO Was Livid Over Protege's Defection to GlaxoSmithKline (GSK) 7/6/2017
Why Theranos Could Burn Through All Its Cash by the End of This Year 7/5/2017
The 2 Biotechs That Turned $8,000 Into at Least $25,600 in Just One Year 7/5/2017
This New Jersey Biotech is Set to Grow EPS by 39,100% Through 2020 7/5/2017
Struggling MannKind (MNKD) Hires Financial Advisor After Maxing Out Its Last Credit Line 6/30/2017
BIO2017: Companies Highlight Numerous Innovations During San Diego Convention 6/27/2017
FDA Calls Cara Therapeutics (CARA)' Kidney Disease Drug a Breakthrough, Stock Soars 6/26/2017
bluebird bio (BLUE) Touts Impressive Data From Late-Stage Gene Therapy Study 6/26/2017
Employee in Critical Condition After Shooting at San Diego Biotech Phamatech 6/23/2017
Amgen (AMGN) Goes on the Defensive When Critics Call Its Pipeline a Dud 6/23/2017
OvaScience (OVAS) Slashes 50% of Workforce, Replaces CEO 6/23/2017
BIO2017: States, Countries Attempt to Woo Companies at BIO 6/23/2017
Seattle Genetics (SGEN) Takes Another Hit as the FDA Slaps Hold on IND for Vadastuximab Talirine 6/23/2017
BIO2017: Companies Use BIO Event to Network and Develop Collaborative Partnerships 6/23/2017
Feds Accuse 'Greedy' Pharmakon Execs of Selling Drugs That Sickened Babies 6/23/2017
Cambridge Biotech Startup Rubius Banks $120 Million, Hopes to Hire 60 New Staffers 6/22/2017
BIO2017: Biotech Dealmaking Will Be Robust in 2017, But Remain Below 2015 Highs 6/22/2017
BIO2017: BIO Urges Biotech Leaders to Get Active on Legislation 6/22/2017
BIO2017: Eli Lilly (LLY) Clinical Development Head Looks to Innovate, Continue Alzheimer’s Research 6/21/2017
BIO2017: Former UK Prime Minister Cameron Calls for More Alzheimer’s Research 6/21/2017
BIO2017: BIO Leaders Honor Memory of Genzyme’s Henri Termeer 6/21/2017
BIO2017: Ann Romney Shares Journey Through MS Treatments, Founding of Neurological Research Center 6/21/2017
Biogen (BIIB) Brings Ex-Shire (SHPG) Exec Into C-Suite 6/21/2017
Governor Launches $500 Million Initiative to Keep Massachusetts' Biotech World Booming 6/20/2017
Bay Area Tech Titan Sean Parker Reaches Out to Unheard-Of Biotech to Confront Immunotherapy 6/20/2017
Inovio Pharma (INO) CEO Forging Multiple Deals, Expanding Pipeline and Adding 100 New Jobs 6/20/2017
Why This Tiny Massachusetts Biotech Could be a New M&A Target for Drug Giants Like Gilead (GILD) and Celgene (CELG) 6/20/2017
Bayer (BAY) Puts Down More Roots in Massachusetts With New Life Science Center 6/20/2017
New Data Reveals This New York Biotech's Pipeline Could be a Game Changer 6/19/2017
Checkmate Notches $27 Million and Taps Ex-FORUM Pharma Exec as COO 6/19/2017
Roche (RHHBY)'s Former New Jersey Site to Become a Life Sciences Campus 6/19/2017
Sonar Products, Stratus Pharma Ordered to Cease Operations 6/16/2017
Why Drug Giants Like Merck & Co. (MRK) and AstraZeneca PLC (AZN) Scientists are Looking in the Toilet for New Cancer Treatments 6/16/2017
Why This Overlooked New Jersey Biotech Could be an Orphan Underdog 6/16/2017
Epizyme (EPZM) Falls as Investors Take in Disappointing Phase II Data 6/16/2017
New Biotech Incubator Just Opened Up in the Big Apple—With Room for 25 Startups 6/16/2017
AstraZeneca PLC (AZN) CEO Warns of More Setbacks, Admits Company is Still Vulnerable to a Takeover 6/15/2017
Meet the Scientist Finding Success at Other Biotechs Working on Old Pfizer (PFE) Compounds 6/14/2017
Hiring Underway at PsiOxus' New Facility in Philadelphia 6/14/2017
Alexion (ALXN) Poaches Biogen (BIIB)'s Longtime CFO 6/14/2017
Deaths Force Merck & Co. (MRK) to Halt Enrollment for Blood Cancer Studies 6/14/2017
Bay Area's Coherus Craters After the FDA Spurns Its Biosimilar for Amgen (AMGN)'s Neulasta 6/13/2017
Landmark Ruling: Amgen (AMGN) Loses Bid to Delay Biosimilars 6/13/2017
SoCal's Regulus (RGLS) Sinks After AstraZeneca PLC (AZN) Bails on Lead NASH Drug 6/13/2017
Meet 7 Bay Area Scientists Changing the Face of Biotech 6/13/2017
Meet GammaDelta Therapeutics's CEO—The Scientist Who Helped GlaxoSmithKline (GSK) Launch 7 Cancer Drugs 6/13/2017
2 Biotechs Insiders Just Bought $70 Million Worth of Stock In 6/12/2017
Hundreds of Patient Deaths Linked to Roche (RHHBY)'s RA Drug Actemra 6/12/2017
The Single Best Hep C Drug Stock to Buy in 2017—Hint, It's Not Gilead (GILD) 6/12/2017
Johnson & Johnson (JNJ) Poaches Merck & Co. (MRK) Exec to Run Pharma R&D 6/12/2017
First Time Ever: FDA Asks Endo Pharma (ENDP) to Stop Selling Opana ER Amid Opioid Crisis 6/9/2017
Booming Glenmark Pharma Could File One NDA Each Year For 10 Years 6/9/2017
Tiny Bay Area Biotech Wants to Rattle the Billion-Dollar Injectable Drug Markets With a Single Pill 6/8/2017
Loxo Oncology (LOXO) Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It 6/8/2017
Debt-Ridden Valeant (VRX) Nears Sale of Its $2 Billion Eye Care Biz Bausch & Lomb 6/7/2017
AstraZeneca PLC (AZN) Eases Its Migraine With $302 Million Sale 6/7/2017
Ramaswamy Launches Another New Biotech to Work on Phase III-Ready Drug From Merck & Co. (MRK) 6/7/2017
Novan Lays Off 20% of Workforce, Switches Up C-Suite 6/6/2017
Acorda (ACOR) Jumps as Parkinson’s Drug Performs Well in Late-Stage Study 6/6/2017
Perrigo (PRGO) CEO to Retire After Only 14 Months on the Job 6/6/2017
Cambridge's 30-Person Cure Forward to Dissolve This Week 6/6/2017
Genentech (RHHBY)’s Perjeta-Based Adjuvant Breast Cancer Care Shows Minor Improvement, Puma Biotech (PBYI) Shares Jump 6/6/2017
New Immuno-Onco Deal With Merck KGaA (MKGAF.PK) Could Make This UK Biotech a $1 Billion Company 6/6/2017
Philadelphia Drugmaker Iroko Pharma Pink Slips Another 122 Employees 6/5/2017
New Alexion (ALXN) CEO Brings Two Former Baxalta (BXLT) Pals and One Pfizer (PFE) Alum Into the C-Suite 6/5/2017
Elated Bristol-Myers Squibb (BMY), Seattle Genetics (SGEN) Rewrite Agreement to Push Promising Drug Combo Into Phase III 6/5/2017
Founding CEO of Editas Medicine (EDIT) Lands New Gig at Top Biotech VC Firm 6/2/2017
Bicycle Therapeutics Snags $52 Million to Take Early Stage Drugs Into Clinic 6/1/2017
Massachusetts' Deciphera Banks $52 Million to Advance Oncology Pipeline 6/1/2017
CRISPR (CRSP), Editas Medicine (EDIT) and Intellia Fall as Scientific Paper Warns of Unintended Mutations Linked to Gene-Editing 6/1/2017
Akari CEO Abruptly Steps Down Amid Investigation Into Phase II Trial Data 6/1/2017
Struggling MannKind (MNKD) Replaces CEO 5/31/2017
Why This Tiny SoCal Biopharma Could be a Real Threat to Mylan (MYL) 5/31/2017
Bay Area Biotech Inks IBD Deal Worth $990 Million With Drug Giant Johnson & Johnson (JNJ) 5/31/2017
Cambridge Biotech Enumeral Biomedical (ENUM) Has Cash to Fund Its Operations Only Into Next Month 5/30/2017
Aerie (AERI) Rockets as Eye Drug Wows in Key Phase III Study 5/30/2017
Roche (RHHBY)'s New MS Drug Linked to Deadly Brain Infection 5/30/2017
How Much Juno (JUNO) Spent on Its Failed CAR-T Drug 5/30/2017
Recruiting Veterans for Life Science Jobs is a Focus at BIO 5/30/2017
26 Patients Dead After Replacing Controller for Abbott (ABT)'s HeartMate II Blood Pumps at Home 5/30/2017
Why Puma Biotech (PBYI) Could Get Acquired Between July to September of This Year 5/30/2017
New FDA Head Lifts Hiring Freeze, Takes Aim at the Next Martin Shkreli and Marathon Pharma 5/30/2017
Biocryst (BCRX) Stock Caught Fire After Reporting Positive Phase II HAE Data 5/26/2017
Top 5 Likable CEOs in Biotech and Pharma 5/26/2017
Silicon Valley VCs Quietly Hiring Biotech Experts 5/25/2017
Puma Biotech (PBYI) Defies Odds, Wins FDA Backing for Breast Cancer Drug 5/25/2017
tranSMART Foundation Teams With IBM (IBM) to Bring Translational Medicine Data to Scientists, Merges With I2B2 5/24/2017
Massive FDA and NIH Cuts in Trump's Outlined Budget Plan 5/24/2017



//-->